Dr. Henry Miller

How are politicians similar to bacteria? ACSH advisor Dr. Henry Miller explains.
The COVID-19 vaccines have been nothing short of miraculous. Life is returning to normal in many places. But ACSH advisor Dr. Henry Miller argues that we will still need effective medical treatments for COVID-19.
What happens when politics and science mix? Scary stuff. Dr. Henry Miller examines the considerable downside of releasing any COVID vaccine prior to the completion of Phase 3 trials. The founding director of the FDA's Office of Biotechnology, Dr. Miller argues that precise science, not the date of an election, is critical at this time.
ACSH advisor Dr. Henry Miller admittedly has "a complicated relationship with viruses." He also knows a lot about them. Here's his take on the one that has arguably captured the attention of nearly every country on Earth.
High-tech medical advances make for sexy headlines, but the use of common-sense low-tech checklists can provide more than an ounce of prevention. ACSH advisor Dr. Henry Miller explains.
Yesterday we reported that ACSH friend, Dr. Henry Miller of the Hoover Institute, wrote a very blunt letter to Dr. Lee Goldman, the Dean of the Faculties of Health Sciences and Medicine at Columbia University, calling for the removal of Dr. Mehmet Oz from the faculty at the university.
Dr. Henry Miller, a highly regarded Research Fellow at the Hoover Institute, who specializes in public health policy, scientific philosophy, junk science and medicine, to name a few, does not find the relationship between Oz and Columbia University the least bit funny.
ACSH friend and former trustee, Dr. Henry Miller of Stanford s Hoover Institution, has another of his typically-erudite and incisive op-eds, this one in today s
In yesterday s New York Times, former ACSH trustee and FDA researcher Drs. Henry Miller, currently at the Hoover Institution, and Jayson Lusk of Oklahoma State University, discuss the various reasons why
ACSH friend Dr. Henry Miller and economist Vasilios Tsimiklis wrote a spot-on piece published on forbes.com detailing the rising health care expenditures in industrialized countries and the necessity for